Search results
Merck could keep its patent edge by shifting Keytruda cancer drug to a simple shot
Reuters via Yahoo News· 1 year agoU.S. drugmaker Merck & Co hopes to patent a new formulation of its $20 billion cancer immunotherapy...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 2 weeks agoMerck MRK reported adjusted earnings of $2.07 per share for first-quarter 2024, beating the Zacks...
Merck Stock Has Been A Laggard For Seven Months. Is It Staging A Comeback?
Investor's Business Daily· 4 months agoMerck stock is shrugging off seven months of underperformance, shooting more than 7% higher in the...
Merck Scores Major Drug Approval, Easing Pain From Keytruda Patent Expiration
Barrons.com· 2 months agoMerck secured Food and Drug Administration approval for a drug widely expected to be an era-defining...
Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
The Wall Street Journal· 2 weeks agoShares of U.S. drugmaker Merck are up nearly 4% in recent trading after the company said its...
Merck scraps third prostate cancer study as Keytruda therapy disappoints
Reuters via Yahoo News· 1 year agoMerck & Co on Tuesday scrapped a late-stage trial of a combination therapy with its cancer drug...
Merck (MRK) Beats on Q3 Earnings & Revenues, Ups 2022 View
Zacks via Yahoo Finance· 2 years agoMerck & Co., Inc. MRK reported third-quarter 2022 adjusted earnings of $1.85 per share, beating the...
Moderna-Merck Partnered Cancer Vaccine Meets Primary Efficacy Endpoint, Stock Jumps
Benzinga via Yahoo Finance· 1 year agoModerna Inc (NASDAQ: MRNA) and Merck & Co Inc (NYSE: MRK) announced the Phase 2b...
Moderna (MRNA), Merck's Cancer Jab Gets EMA's PRIME Tag
Zacks via Yahoo Finance· 1 year agoThe EMA grants PRIME designation to Moderna's (MRNA) personalized cancer vaccine candidate combined...
Merck (MRK) Beats on Q4 Earnings & Sales, 2023 View Disappoints
Zacks via Yahoo Finance· 1 year agoMerck MRK reported fourth-quarter 2022 adjusted earnings of $1.62 per share, which beat the Zacks...